Skip to main content
Selim Arcasoy, MD, Pulmonology, New York, NY

SelimMehmetArcasoyMDMPH

Pulmonology New York, NY

Critical Care Medicine, Cystic Fibrosis, Interstitial Lung Diseases, Lung Transplantation Medicine

Professor of Medicine, Columbia University

Overview of Dr. Arcasoy

Dr. Arcasoy was recruited to Columbia University/NewYork-Presbyterian Hospital as the Medical Director of Lung Transplant Program in 2001 from the University of Pennsylvania, where he was a key member of the Advanced Lung Disease and Lung Transplantation Program. After his recruitment, he completely turned around the Lung Transplant Program to rank amongst the top 3 programs in the country. Under his leadership, the Lung Transplant Program has performed nearly 1,500 lung transplants in the past two decades and more than 100 transplants annually in the past 4 years since 2020. Despite high transplant volumes and very sick pretransplant candidates, the survival of lung transplant recipients has remained significantly above the national average. Currently, 1-year survival of lung transplant recipients at Columbia University is 90%, 5-year survival 65%, and 10-year survival 40%.
Dr. Arcasoy has gained national and international reputation with various leadership roles in many professional organizations and scientific societies. He previously chaired the Thoracic Organ Transplant Committee of the American Society of Transplantation and the Transplant Network Steering Committee of the American College of Chest Physicians. Dr. Arcasoy is a Fellow of the American College of Physicians (FACP), American College of Chest Physicians (FCCP), and American Society of Transplantation (FAST). He is in a leadership position in the Standards&Guidelines Committee of the International Society of Heart and Lung Transplantation. He also serves as a reviewer for many scientific journals. Dr. Arcasoy has been named in America's Top Doctors and Top Doctors: New York Metro area in the past 20 consecutive years. He has been selected in the New York Times Super Doctors list in the past 10 years.
Dr. Arcasoy's main research interests include outcomes of patients with advanced lung disease before and after lung transplantation and clinical trials in new immunosuppressive therapies.

Education & Training

  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsM.P.H., Public Health in Healthcare Management, 2011 - 2013
  • UPMC Medical Education
    UPMC Medical EducationFellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1998
  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1990 - 1994
  • Ege Univ- Fac Med
    Ege Univ- Fac MedClass of 1990
  • Tarsus American College
    Tarsus American CollegeBachelors, 1977 - 1984

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1992 - 2025
  • NJ State Medical License
    NJ State Medical License 2004 - 2025
  • NY State Medical License
    NY State Medical License 1993 - 2025
  • PA State Medical License
    PA State Medical License 1994 - 2002
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • New York City Super Doctors New York Times Magazine, 2009-2024
  • America's Top Doctors Castle Connolly, 2003-2014, 2016-2020
  • New York Magazine: Top Doctors Castle Connolly, 2002-2007, 2010, 2019-2020
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis  
    Eur Resp J, 1/1/2013
  • Interobserver variability in grading transbronchial lung biopsies after lung transplantation  
    Chest, 1/1/2013
  • Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation  
    Transl Res, 1/1/2012
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Elevated Monocyte Chemotactic Protein-1 (MCP-1) Is Associated With Primary Graft Dysfunction Following Lung Transplantation
    Am J Respir Crit Care Med, 1/1/2011
  • PTX3 Polymorphisms Are Associated with Primary Graft Dysfunction after Lung Transplantation
    J Heart Lung Transplant, 1/1/2011
  • Elevated PTX3 Concentration Is Associated with Primary Graft Dysfunction after Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis
    J Heart Lung Transplant, 1/1/2011
  • Join now to see all

Lectures

  • International Collaboration in Lung Transplantation 
    Istanbul, Turkey - 1/1/2013
  • Lung Transplantation. 2013 Update 
    Medica Health Clinic, Istanbul, Turkey - 1/1/2013
  • Lung Transplantation in Interstitial Lung Disease and Pulmonary Fibrosis 
    Columbia University College of Physicians and Surgeons and NewYork-Presbyterian Hospital, White Plai - 1/1/2012
  • Join now to see all

Other

Authored Content

  • My Spotify Podcast about Advances in Lung TransplantationJune 2024

Press Mentions

  • Expert Experience: Achieving Greater Success in Lung Transplantation Through Access & Innovation
    Expert Experience: Achieving Greater Success in Lung Transplantation Through Access & InnovationJune 17th, 2024
  • Lung Patients See a New Era of Transplants
    Lung Patients See a New Era of TransplantsSeptember 24th, 2006
  • At the Leading Edge of Lung Transplantation
    At the Leading Edge of Lung TransplantationApril 17th, 2024
  • Join now to see all

Grant Support

  • Pathogenesis Of Airway Disease In Cystic FibrosisNational Heart, Lung, And Blood Institute1996–1997

Committees

  • Associate Chair, Advanced Lung Failure and Lung Transplant, Standards and Guidelines, ISHLT 2019 - 2024

Professional Memberships

Other Languages

  • Turkish

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS North Carolina BlueOptions PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Great West PPO
    Healthfirst New York
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment